Detalhe da pesquisa
1.
Visualizing Engrafted Human Cancer and Therapy Responses in Immunodeficient Zebrafish.
Cell
; 177(7): 1903-1914.e14, 2019 06 13.
Artigo
em Inglês
| MEDLINE | ID: mdl-31031007
2.
SETDB1 tumour suppressor roles in near-haploid mesothelioma involve TP53.
Br J Cancer
; 129(3): 531-540, 2023 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-37369845
3.
Targeting DNA-PK.
Cancer Treat Res
; 186: 299-312, 2023.
Artigo
em Inglês
| MEDLINE | ID: mdl-37978142
4.
Strategies to inhibit FGFR4 V550L-driven rhabdomyosarcoma.
Br J Cancer
; 127(11): 1939-1953, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36097178
5.
Concurrent inhibition of CDK2 adds to the anti-tumour activity of CDK4/6 inhibition in GIST.
Br J Cancer
; 127(11): 2072-2085, 2022 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-36175617
6.
Mutational inactivation of mTORC1 repressor gene DEPDC5 in human gastrointestinal stromal tumors.
Proc Natl Acad Sci U S A
; 116(45): 22746-22753, 2019 11 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-31636198
7.
Relationships between highly recurrent tumor suppressor alterations in 489 leiomyosarcomas.
Cancer
; 127(15): 2666-2673, 2021 08 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33788262
8.
Mesenchymal tumors of the gastrointestinal tract with NTRK rearrangements: a clinicopathological, immunophenotypic, and molecular study of eight cases, emphasizing their distinction from gastrointestinal stromal tumor (GIST).
Mod Pathol
; 34(1): 95-103, 2021 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-32669612
9.
Gastrointestinal stromal tumor enhancers support a transcription factor network predictive of clinical outcome.
Proc Natl Acad Sci U S A
; 115(25): E5746-E5755, 2018 06 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-29866822
10.
Coordinated targeting of CK2 and KIT in gastrointestinal stromal tumours.
Br J Cancer
; 122(3): 372-381, 2020 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-31776458
11.
Clinical value of next generation sequencing of plasma cell-free DNA in gastrointestinal stromal tumors.
BMC Cancer
; 20(1): 99, 2020 Feb 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-32024476
12.
Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours.
Br J Cancer
; 120(6): 612-620, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30792533
13.
Correction: Complementary activity of tyrosine kinase inhibitors against secondary kit mutations in imatinib-resistant gastrointestinal stromal tumours.
Br J Cancer
; 121(3): 281, 2019 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-31123346
14.
BPR1J373, a novel multitargeted kinase inhibitor, effectively suppresses the growth of gastrointestinal stromal tumor.
Cancer Sci
; 109(11): 3591-3601, 2018 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-30142229
15.
ALK oncoproteins in atypical inflammatory myofibroblastic tumours: novel RRBP1-ALK fusions in epithelioid inflammatory myofibroblastic sarcoma.
J Pathol
; 241(3): 316-323, 2017 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-27874193
16.
Thyroid hormone inactivation in gastrointestinal stromal tumors.
N Engl J Med
; 370(14): 1327-34, 2014 Apr 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-24693892
17.
What is New in Gastrointestinal Stromal Tumor?
Adv Anat Pathol
; 24(5): 259-267, 2017 Sep.
Artigo
em Inglês
| MEDLINE | ID: mdl-28632504
18.
Alternate PAX3-FOXO1 oncogenic fusion in biphenotypic sinonasal sarcoma.
Genes Chromosomes Cancer
; 55(1): 25-9, 2016 Jan.
Artigo
em Inglês
| MEDLINE | ID: mdl-26355893
19.
ALK-rearranged renal cell carcinomas in children.
Genes Chromosomes Cancer
; 55(5): 442-51, 2016 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-26773439
20.
Inhibition of Bcl-2 family members sensitizes mesenchymal chondrosarcoma to conventional chemotherapy: report on a novel mesenchymal chondrosarcoma cell line.
Lab Invest
; 96(10): 1128-37, 2016 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-27617402